AMENDMENT NO. 3 TO NOTE EXCHANGE AND PURCHASE AGREEMENTNote Exchange and Purchase Agreement • February 28th, 2013 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2013 Company Industry JurisdictionThis Amendment to Note Exchange and Purchase Agreement (“Amendment No. 3”) is entered into as of February 22, 2013 by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”) and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”). Unless otherwise specified herein, all capitalized terms set forth in this Amendment shall have the meanings as set forth in the Agreement.
AMENDMENT TO NOTE EXCHANGE AND PURCHASE AGREEMENTNote Exchange and Purchase Agreement • November 20th, 2012 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 20th, 2012 Company Industry JurisdictionThis Amendment to Note Exchange and Purchase Agreement (the “Amendment”) is entered into as of November 14, 2012 by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”) and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”). Unless otherwise specified herein, all capitalized terms set forth in this Amendment shall have the meanings as set forth in the Agreement.
NOTE EXCHANGE AND PURCHASE AGREEMENT Dated as of October 11, 2012 By and Between VISTAGEN THERAPEUTICS, INC. and PLATINUM LONG TERM GROWTH VII, LLCNote Exchange and Purchase Agreement • October 16th, 2012 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 16th, 2012 Company Industry JurisdictionThis Note Exchange and Purchase Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is dated as of October 11, 2012 by and between VISTAGEN THERAPEUTICS, INC., a Nevada corporation (the “Company”), and PLATINUM LONG TERM GROWTH VII, LLC, a Delaware limited liability company (“Platinum”).
AMENDMENT NO. 2 TO NOTE EXCHANGE AND PURCHASE AGREEMENTNote Exchange and Purchase Agreement • February 14th, 2013 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 14th, 2013 Company Industry JurisdictionThis Amendment to Note Exchange and Purchase Agreement (“Amendment No. 2”) is entered into as of January 31, 2013 by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”) and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”). Unless otherwise specified herein, all capitalized terms set forth in this Amendment shall have the meanings as set forth in the Agreement.